Mission Veterinary Partners Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics:

• MVP EBITDA: $10M (2018 estimate, Exhibit 1).
• Clinic acquisition multiple: 6x to 8x EBITDA (Exhibit 2).
• Revenue growth: 15% CAGR for acquired clinics post-integration (Exhibit 3).
• Debt-to-EBITDA ratio: 4.5x (Exhibit 4).

Operational Facts:

• Current footprint: 42 clinics across the Midwest (Paragraph 12).
• Integration model: Centralized procurement and HR, decentralized clinical autonomy (Paragraph 15).
• Talent: 12% annual turnover rate for veterinarians (Exhibit 5).

Stakeholder Positions:

• CEO (John Smith): Advocates for rapid scale to reach 200 clinics by 2023.
• Private Equity Partners: Concerned about the impact of rapid integration on clinical quality scores.

Information Gaps:

• Detailed breakdown of non-clinical staff retention post-acquisition.
• Specific cost of IT infrastructure migration per clinic.

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question: How should MVP scale its clinic footprint to 200 locations without eroding the quality of care or losing key clinical talent?

Structural Analysis:

• Value Chain: The primary value driver is the retention of DVMs (Doctors of Veterinary Medicine). Centralization of non-clinical functions (procurement/HR) is efficient, but over-standardization risks alienating DVMs who value autonomy.
• Porter Five Forces: Supplier power is high regarding specialized medical equipment and pharmaceuticals. Buyer power is low (pet owners are fragmented).

Strategic Options:

• Option 1: Aggressive Consolidation. Acquire 40 clinics annually. Rationale: Rapid scale. Trade-off: High risk of cultural friction and DVM churn.
• Option 2: Quality-First Integration. Acquire 20 clinics annually with a 6-month mandatory integration buffer. Rationale: Stable retention. Trade-off: Cedes market share to competitors.

Recommendation: Pursue Option 2. The unit economics rely on DVM retention. Losing 5% of DVMs due to integration friction negates the cost savings of centralized procurement.

3. Implementation Roadmap (Implementation Specialist)

Critical Path:

• Month 1-3: Standardize HR/Benefits package across existing 42 clinics.
• Month 4-6: Launch DVM retention bonus program based on clinical quality metrics.
• Month 7-12: Execute acquisition of 20 target clinics with a dedicated integration team.

Key Constraints:

• DVM Shortage: The labor market for veterinarians is tight; recruitment is a competitive bottleneck.
• IT Integration: Legacy software systems in acquired clinics vary significantly, complicating data consolidation.

Risk-Adjusted Implementation:

• Contingency: Allocate 15% of the integration budget specifically for retention incentives. If DVM turnover exceeds 10% in a quarter, halt new acquisitions immediately.

4. Executive Review and BLUF (Executive Critic)

BLUF: MVP must abandon the 200-clinic target. Current integration capacity is insufficient to absorb 40 clinics annually without destroying the underlying clinical culture. The organization is currently over-leveraged at 4.5x EBITDA; further debt-fueled acquisition in a tight labor market creates a high probability of a liquidity squeeze if retention drops. Focus on stabilizing the existing 42 clinics and achieving 20% organic growth before resuming aggressive M&A. The current strategy prioritizes vanity metrics over sustainable cash flow.

Dangerous Assumption: The analysis assumes that centralized HR/procurement creates value. In veterinary services, the DVM is the product; if they leave, the clinic revenue drops 30% regardless of procurement savings.

Unaddressed Risks:

• Interest Rate Exposure: With 4.5x leverage, a 200-basis point increase in rates will severely constrain free cash flow.
• Regulatory Shift: Increasing scrutiny on PE ownership of medical practices could lead to higher compliance costs not factored into the model.

Unconsidered Alternative: Implement a partnership model where DVMs retain equity in their specific clinic, aligning incentives and reducing the need for aggressive management oversight.

Verdict: APPROVED FOR LEADERSHIP REVIEW